Cronos Group (CRON) Stock Forecast, Price & News

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CRON shares.
View CRON analyst ratings or view top-rated stocks.

6 analysts have issued 12 month target prices for Cronos Group's stock. Their CRON share price forecasts range from $3.00 to $4.75. On average, they expect the company's share price to reach $3.44 in the next twelve months. This suggests a possible upside of 96.4% from the stock's current price.
View analysts price targets for CRON or view top-rated stocks among Wall Street analysts.

Cronos Group's stock was trading at $2.54 at the beginning of the year. Since then, CRON shares have decreased by 31.1% and is now trading at $1.75.
View the best growth stocks for 2023 here.

Cronos Group saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 8,230,000 shares, a drop of 12.6% from the April 30th total of 9,420,000 shares. Based on an average daily volume of 1,490,000 shares, the short-interest ratio is presently 5.5 days. Currently, 4.1% of the shares of the company are sold short.
View Cronos Group's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023.
View our CRON earnings forecast.

Cronos Group Inc. (NASDAQ:CRON) posted its earnings results on Thursday, August, 5th. The company reported $0.15 earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.22. The business earned $15.60 million during the quarter, compared to the consensus estimate of $18.48 million. Cronos Group had a negative trailing twelve-month return on equity of 9.65% and a negative net margin of 178.43%. The firm's revenue was up 57.6% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.31) earnings per share.

Cronos Group issued an update on its FY 2023 earnings guidance on Tuesday, May, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $100.00 million-$110.00 million, compared to the consensus revenue estimate of $102.93 million.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Aurora Cannabis (ACB), Tilray (TLRY), NVIDIA (NVDA), Advanced Micro Devices (AMD), Dollar Tree (DLTR), Micron Technology (MU), Alibaba Group (BABA) and Organigram (OGI).

Cronos Group trades on the NASDAQ under the ticker symbol "CRON."

Cronos Group's stock is owned by a number of retail and institutional investors. Top institutional investors include ETF Managers Group LLC (1.45%), Dimensional Fund Advisors LP (0.39%), Intact Investment Management Inc. (0.30%), Mirae Asset Global Investments Co. Ltd. (0.26%), Penserra Capital Management LLC (0.14%) and Swiss National Bank (0.12%). Insiders that own company stock include Jason Marc Adler, Michael Ryan Gorenstein and Todd Kevin Abraham.
View institutional ownership trends.

Shares of CRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CRON stock can currently be purchased for approximately $1.75.

Cronos Group (NASDAQ:CRON) has a market capitalization of $666.44 million and generates $91.90 million in revenue each year. The company earns $-168,730,000.00 in net income (profit) each year or ($0.41) on an earnings per share basis.

The company employs 626 workers across the globe.

Cronos Group's mailing address is 111 PETER STREET SUITE 300, TORONTO A6, M5V 2G9. The official website for the company is www.thecronosgroup.com. The company can be reached via phone at (416) 504-0004.